middle.news
Inhalerx Draws $247K to Fuel Phase 2 Trials, Cash Burn Hits $310K This Quarter
7:10pm on Friday 31st of October, 2025 AEDT
•
Healthcare
Read Story
Inhalerx Draws $247K to Fuel Phase 2 Trials, Cash Burn Hits $310K This Quarter
7:10pm on Friday 31st of October, 2025 AEDT
Key Points
Drawdown of $247,000 from $38.5 million clinical trial funding facility
Operating cash outflow of $310,000 for the quarter
Cash and cash equivalents at $170,000 at quarter-end
Unused financing facility balance of $38.236 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
IRX
OPEN ARTICLE